Business Context and Reporting Period
This Form 8-K was filed by Conversion Labs, Inc. on October 15, 2020, reporting events occurring on October 9, 2020. The filing addresses a corporate action involving the Company's capital structure. Note: The request metadata references "Lifemd, Inc.," but the filing text explicitly identifies the registrant as "Conversion Labs, Inc."
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report focused solely on a corporate governance event.
Material Changes
- Reverse Stock Split: The Company filed a Certificate of Amendment to its Articles of Incorporation to effectuate a 1-for-5 reverse stock split of its issued and outstanding common stock.
- Regulatory Approval: The reverse split was approved by the Financial Industry Regulatory Authority (FINRA).
- Effective Date: The reverse split became effective in the market on October 14, 2020.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document strictly reports the execution of the reverse stock split and references the attached Certificate of Amendment (Exhibit 3.1) for complete legal details.
Investor Verification Checklist
- Verify the post-split share count and adjusted share price on October 14, 2020.
- Confirm the Company's current trading symbol and exchange status, as the filing lists "None" for registered securities at the time of this report.
- Review Exhibit 3.1 (Certificate of Amendment) for specific terms regarding fractional shares or rounding procedures.
- Check subsequent filings to confirm if the Company has since listed its securities on a national exchange.